A*STAR, Cytos Biotechnology provide update on Phase 1 clinical trial of H1N1 ...

17-05-2013 News-Medical.netComments (0)

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on ...

Read more on News-Medical.net

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top